Literature DB >> 28110019

Cancer cell metabolism and mitochondria: Nutrient plasticity for TCA cycle fueling.

Cyril Corbet1, Olivier Feron2.   

Abstract

Warburg's hypothesis that cancer cells take up a lot of glucose in the presence of ambient oxygen but convert pyruvate into lactate due to impaired mitochondrial function led to the misconception that cancer cells rely on glycolysis as their major source of energy. Most recent 13C-based metabolomic studies, including in cancer patients, indicate that cancer cells may also fully oxidize glucose. In addition to glucose-derived pyruvate, lactate, fatty acids and amino acids supply substrates to the TCA cycle to sustain mitochondrial metabolism. Here, we discuss how the metabolic flexibility afforded by these multiple mitochondrial inputs allows cancer cells to adapt according to the availability of the different fuels and the microenvironmental conditions such as hypoxia and acidosis. In particular, we focused on the role of the TCA cycle in interconnecting numerous metabolic routes in order to highlight metabolic vulnerabilities that represent attractive targets for a new generation of anticancer drugs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fatty acid; Glucose; Glutamine; Metabolism; Mitochondria; Tumor

Mesh:

Substances:

Year:  2017        PMID: 28110019     DOI: 10.1016/j.bbcan.2017.01.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  53 in total

Review 1.  Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation.

Authors:  Sharanya Sivanand; Isabella Viney; Kathryn E Wellen
Journal:  Trends Biochem Sci       Date:  2017-11-23       Impact factor: 13.807

Review 2.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 3.  Tumour acidosis: from the passenger to the driver's seat.

Authors:  Cyril Corbet; Olivier Feron
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

4.  The many metabolic sources of acetyl-CoA to support histone acetylation and influence cancer progression.

Authors:  Olivier Feron
Journal:  Ann Transl Med       Date:  2019-12

5.  Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.

Authors:  Wilson I Gonsalves; Vijay Ramakrishnan; Taro Hitosugi; Toshi Ghosh; Dragan Jevremovic; Tumpa Dutta; Dhananjay Sakrikar; Xuan-Mai Petterson; Linda Wellik; Shaji K Kumar; K Sreekumaran Nair
Journal:  JCI Insight       Date:  2018-01-11

6.  Aberrant shuttling of long noncoding RNAs during the mitochondria-nuclear crosstalk in hepatocellular carcinoma cells.

Authors:  Yijing Zhao; Shanshan Liu; Lei Zhou; Xueli Li; Ying Meng; Yan Li; Lingyu Li; Benzheng Jiao; Ling Bai; Yu Yu; Songling Zhang; Wei Li; Andrew R Hoffman; Ji-Fan Hu; Jiuwei Cui
Journal:  Am J Cancer Res       Date:  2019-05-01       Impact factor: 6.166

7.  Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Wendy Bloomer; Christopher I Amos; Jeffrey E Lee; Xin Li; Hongmei Nan; Qingyi Wei
Journal:  Mol Carcinog       Date:  2019-08-22       Impact factor: 4.784

8.  Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.

Authors:  Riva Shmulevich; Tsipi Ben-Kasus Nissim; Ido Wolf; Keren Merenbakh-Lamin; Daniel Fishman; Israel Sekler; Tami Rubinek
Journal:  Oncogene       Date:  2020-05-12       Impact factor: 9.867

9.  Brain Endothelial Cells: Metabolic Flux and Energy Metabolism.

Authors:  Cade J McDonald; Zachery J Blankenheim; Lester R Drewes
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.

Authors:  Jung Ho Han; MinJeong Kim; Hyeon Jin Kim; Se Bok Jang; Sung-Jin Bae; In-Kyu Lee; Dongryeol Ryu; Ki-Tae Ha
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.